TrialPloS one2024

Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial.

Bruno Martins Tomazini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.